Page 75 - Demo

75 About Strategy and Governance Our People Our Business Our Outcome AppendixProduct Quality and Safety Our Impacts Our business is built on trust and integrity: Our clients entrust us with marketing and distributing their products and expect us to preserve the quality and safety of their goods while under our care and custody. Business Unit Healthcare improves people%u2019s quality of life through providing access to healthcare, while Business Unit Consumer Goods promotes access to high-quality consumer goods. Business Unit Performance Materials positively influences the safety and quality of end products by providing specialty chemicals and ingredients. Business Unit Technology%u2019s focus is on safe and high-quality technology equipment.We know that product integrity and supply issues have different positive and negative impacts on people, including their human rights, and on society as a whole. We have positive impacts by combatting the spread of counterfeit products; this protects people and society against harmful effects. However, potential negative impacts may exist if we trade in products with health risks to consumers, such as medicines with dangerous side effects.Attaining the Highest StandardsWe have quality management systems in place across all product categories to ensure we meet the high standards necessary to safeguard the health and safety of customers, consumers, and patients. Furthermore, we ensure that all our products originate from authentic manufacturing processes, thereby avoiding potential safety issues associated with counterfeit products.Our management approach is tailored to the different Business Units and product categories we handle and the regulations governing them. Products in the healthcare sector must prioritize patient safety, meet stringent quality standards specified by clients and regulators, and comply with international guidelines (e.g. from the World Health Organization, the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use, and the Pharmaceutical Inspection Co-operation Scheme). We observe the Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards when distributing and manufacturing our products. All our healthcare distribution facilities are approved by respective local health authorities with the appropriate internationally recognized quality management system certification (e.g. ISO 9001 and ISO 13485). Our regulatory affairs specialists handle any issues related to product safety in keeping with stringent pharmacovigilance procedures.Food safety is another significant concern we address through quality management procedures, whether for finished goods distributed by our Consumer Goods business or food ingredients marketed by our Performance Materials business. Our quality assurance and regulatory affairs teams make sure that our products and operations comply with regulations set by the respective food and drug administrations in our markets. Handling chemicals poses a different set of challenges, which we manage through stringent safety and due diligence procedures based on applicable standards, including ISO 9000, the Classification, Labeling and Packaging (CLP) Regulation, and our own Standard Operating Procedures (SOPs), as well as DKSH%u2019s Health, Safety and Environment (HSE) policy. These procedures are enhanced by a new HSE Management System and new guidelines for managing hazardous chemicals and dangerous goods, developed in 2020 and enacted in 2021. In 2022, we received ISO 9001 certification for Business Unit Performance Materials%u2019 distribution center in Indonesia.